TTM
$8.92B
YoY change
-7.9%
5Y CAGR
+3.4%
Peak year (2023)
$10.49B
Cumulative EBITDA
$154.42B
EBITDA history chart for Elevance Health (ELV) from 1998 to 2025
Latest: $9.66B
EBITDA growth chart for Elevance Health (ELV) from 1998 to 2025
Latest: -7.9%
EBITDA history table for Elevance Health (ELV) from 1998 to 2025
| 2025 | $9.66B | -7.9% | −$824.00M | ||
| 2024 | $10.48B | -0.1% | −$8.00M | ||
| 2023 | $10.49B | +3.6% | +$364.00M | ||
| 2022 | $10.13B | +1.0% | +$101.00M | ||
| 2021 | $10.03B | +22.6% | +$1.85B | ||
| 2020 | $8.18B | +4.0% | +$312.00M | ||
| 2019 | $7.86B | +13.1% | +$911.00M | ||
| 2018 | $6.95B | +24.3% | +$1.36B | ||
| 2017 | $5.59B | -9.6% | −$597.00M | ||
| 2016 | $6.19B | -0.0% | −$1.70M | ||
| 2015 | $6.19B | +6.4% | +$372.10M | ||
| 2014 | $5.82B | +8.7% | +$468.10M | ||
| 2013 | $5.35B | +4.7% | +$240.90M | ||
| 2012 | $5.11B | +1.7% | +$85.40M | ||
| 2011 | $5.03B | -6.5% | −$348.10M | ||
| 2010 | $5.37B | -36.1% | −$3.03B | ||
| 2009 | $8.40B | +100.9% | +$4.22B | ||
| 2008 | $4.18B | -33.4% | −$2.10B | ||
| 2007 | $6.28B | +6.3% | +$369.50M | ||
| 2006 | $5.91B | +43.6% | +$1.79B | ||
| 2005 | $4.12B | +122.0% | +$2.26B | ||
| 2004 | $1.85B | +16.3% | +$259.40M | ||
| 2003 | $1.60B | +524.4% | +$1.34B | ||
| 2002 | $255.50M | -58.5% | −$360.80M | ||
| 2001 | $616.30M | — | +$616.30M | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | — |
- 2025$9.66B-7.9%
- 2024$10.48B-0.1%
- 2023$10.49B+3.6%
- 2022$10.13B+1.0%
- 2021$10.03B+22.6%
- 2020$8.18B+4.0%
- 2019$7.86B+13.1%
- 2018$6.95B+24.3%
- 2017$5.59B-9.6%
- 2016$6.19B-0.0%
- 2015$6.19B+6.4%
- 2014$5.82B+8.7%
- 2013$5.35B+4.7%
- 2012$5.11B+1.7%
- 2011$5.03B-6.5%
- 2010$5.37B-36.1%
- 2009$8.40B+100.9%
- 2008$4.18B-33.4%
- 2007$6.28B+6.3%
- 2006$5.91B+43.6%
- 2005$4.12B+122.0%
- 2004$1.85B+16.3%
- 2003$1.60B+524.4%
- 2002$255.50M-58.5%
- 2001$616.30M—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
EBITDA values are taken from Elevance Health's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Elevance Health (ELV)
According to Elevance Health's latest reported financial statements, the company's current EBITDA (TTM) is $8.92B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Elevance Health (ELV) EBITDA totalled $9.66B – declined 7.9% year-over-year.
Through 2020–2025 (5 years), Elevance Health EBITDA delivered a +3.4% annualised rate; with mixed annual results across the window.
Elevance Health EBITDA declined from $10.49B in 2023 to $9.66B in 2025, a 7.9% drawdown.
2023 marks the peak EBITDA at $10.49B, with the historical low of $0.00 recorded in 1998.
Elevance Health EBITDA by Year
Elevance Health EBITDA 2025: $9.66B
2025's EBITDA for Elevance Health came in at $9.66B, declined 7.9% below 2024.
Elevance Health EBITDA 2024: $10.48B
Elevance Health posted EBITDA of $10.48B in 2024, edged down 0.1% below 2023.
Elevance Health EBITDA 2023: $10.49B
In 2023, Elevance Health reported EBITDA of $10.49B, edged up 3.6% from 2022. This figure represents the highest annual value in the available history.
Elevance Health EBITDA 2022: $10.13B
Elevance Health EBITDA in 2022 was $10.13B, edged up 1.0% from 2021.
Elevance Health EBITDA 2021: $10.03B
Elevance Health EBITDA in 2021 was $10.03B.
See more financial history for Elevance Health (ELV).
Sector peers by EBITDA
Healthcare peers of Elevance Health (ELV), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation